Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RayzeBio, Inc.
RayzeBio, Inc.
National Institutes of Health Clinical Center (CC)
RayzeBio, Inc.
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Cedars-Sinai Medical Center
M.D. Anderson Cancer Center
CHU de Reims
Fox Chase Cancer Center
Hospices Civils de Lyon
Merck Sharp & Dohme LLC
Queen Mary University of London
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Advanced Accelerator Applications
CHU de Quebec-Universite Laval
Hutchmed
AC Camargo Cancer Center
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Roswell Park Cancer Institute
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
University of Alabama at Birmingham
Dana-Farber Cancer Institute
Radio Isotope Therapy of America
H. Lee Moffitt Cancer Center and Research Institute
British Columbia Cancer Agency
Provectus Pharmaceuticals
Ipsen
University of Chicago
University of Iowa
Novartis
Amgen
Novartis
Novartis
University of Iowa
University of California, San Francisco
H. Lee Moffitt Cancer Center and Research Institute
King's College Hospital NHS Trust
M.D. Anderson Cancer Center
University of California, San Francisco
Eli Lilly and Company
Massachusetts General Hospital
Novartis
Arbutus Biopharma Corporation
H. Lee Moffitt Cancer Center and Research Institute
CHU de Reims
Western University, Canada
Dana-Farber Cancer Institute